Navigation Links
Pharmasset to Present at Lazard Capital Markets Healthcare Conference
Date:11/9/2009

ing our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2008 and our Quarterly Report on Form 10-Q for the period ended June 30, 2009 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.

SOURCE Pharmasset, Inc.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
2. Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
3. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
4. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
5. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
6. Pharmasset Reports Fiscal Year End 2008 Financial Results
7. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
8. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
9. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
10. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
11. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013   NextDocs announced today that ... research organization, at DIA 2013 , the Drug ... present case studies that explore best practices for making ... trial master file (eTMF) systems. Sharon ... alongside Krystyna Kowalczyk , executive vice president of ...
(Date:6/19/2013)... 19, 2013  Finesse Solutions, Inc, a manufacturer ... process applications, announced the launch of its new ... culture and fermentation.  The 3L glass vessels are ... Finesse bioreactors and are designed to optimize yield ... fully compatible with all Finesse G3Lab controllers, and ...
(Date:6/19/2013)... 19, 2013 ... DrugPatentWatch to its extensive list of ...      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) , ... pharmaceutical, drug patents and their expirations. ... business functions of patent agents and ...
Breaking Medicine Technology:NextDocs and Novella to Present on eTMF at DIA 2013 2Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Drug Patent Watch 2Drug Patent Watch 3
... TEL AVIV, Israel , ... advanced products for the non invasive, accurate,diagnosis of heart ... ( http://www.bsp.co.il/pdf/HyperQ AD-100 Pic.pdf), intended for,improved diagnostic performance ... mark. The HyperQ AD-100 product is an add-on system ...
... ALLEGAN, Mich. , June 29 Perrigo (Nasdaq: ... the exclusive U.S. store brand rights to sell and distribute ... tabs, plus Fexofenadine HCl 60 mg and Pseudoephedrine 120 mg ... products. Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) currently ...
Cached Medicine Technology:BSP Granted CE Mark for its HyperQ AD-100 Product Enabling Improved Diagnostic Performance of Stress ECG 2Perrigo Acquires Exclusive Sales and Distribution Rights to OTC Store Brand Versions of Allegra® and Allegra D-12 From Teva 2Perrigo Acquires Exclusive Sales and Distribution Rights to OTC Store Brand Versions of Allegra® and Allegra D-12 From Teva 3
(Date:6/19/2013)... (June 19, 2013) In early April, senior leaders ... in Hartford, Connecticut, to discuss one question: how can ... , The preliminary results of this discussion ... Shooter Events: The Hartford Consensus ," a concept paper ... Journal of Trauma and Acute Care Surgery ...
(Date:6/19/2013)... 70 percent of Americans are on at least ... two, Mayo Clinic researchers say. Antibiotics, antidepressants and ... found. Twenty percent of patients are on five ... published online in the journal Mayo Clinic ... video of Dr. Jennifer St. Sauver talking about ...
(Date:6/19/2013)... Effective Environmental Services and Clifford Woods, CEO, ... online links are devoted to a range of organic and ... Control Mold Magician and others. , Green products are easy ... the water as well as living plants. They contain beneficial ... accumulate at the bottom of a pond and render the ...
(Date:6/19/2013)... Japan Leading Japanese pharmaceutical companies, along with ... Gates Foundation, pledged their commitment to bolster Japan,s ... Innovative Technology Fund (GHIT Fund), at a press ... fifth Tokyo International Conference on African Development (TICAD ... including the Ministry of Health, Labour and ...
(Date:6/19/2013)... June 19, 2013 Dental professionals are ... because from minor to moderate sedation, a patient’s breathing ... of Dentistry is the latest to update its guidelines ... deep sedation in an effort to increase safety in ... Dental Practice Act goes into effect July 1. ...
Breaking Medicine News(10 mins):Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:Effective Environmental Services Launch New Websites to Serve Customers 2Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 2Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 3Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3
... have developed an ultra-sensitive test that should enable them to ... research published today in the journal Nature Materials . ... University of Vigo, have created a test to detect particular ... are in very low concentrations. There are already tests available ...
... May 27 (HealthDay News) -- Boosting students, levels of ... says. Swedish researchers followed more than 200 schoolchildren, ... Some children were assigned to an intervention group that ... training in motor-physical skills such as balance and coordination. ...
... than half of Americans with individual market health insurance coverage ... less coverage than the lowest "bronze"-level plans in the Affordable ... offered in the health insurance exchanges that are being created ... today as a Web First in the journal Health ...
... 25 (HealthDay News) -- People with inflammatory bowel disease, ... increased risk for flare-ups when they fly or travel ... new study suggests. This complications affected patients with ... or ulcerative colitis (which typically involves the large intestine ...
... Thompson HealthDay Reporter , FRIDAY, May 25 (HealthDay ... severe emotional turmoil find relief in physical pain -- cutting ... form of release. But researchers now are questioning whether ... people and help them before they do themselves irreparable damage. ...
... (HealthDay News) -- Phthalates in PVC flooring materials can ... These chemicals -- which are suspected to cause ... can be ingested with food, by breathing and through ... in Sweden. Phthalates are softening agents found in ...
Cached Medicine News:Health News:Super-sensitive tests could detect diseases earlier 2Health News:Half of Americans with individual health plans could gain better coverage under the ACA 2Health News:Half of Americans with individual health plans could gain better coverage under the ACA 3Health News:Half of Americans with individual health plans could gain better coverage under the ACA 4Health News:Travel to High Altitudes Tied to Crohn's, Colitis Flare-Ups 2Health News:More Mental Health Care Urged for Kids Who Self-Harm 2Health News:More Mental Health Care Urged for Kids Who Self-Harm 3
... The Euclid Systems Orthokeratology (oprifocon A) ... contact lenses used for orthokeratology, a ... The patient wears these lenses overnight ... During the day, nearsightedness is temporarily ...
... for a way to help your patients ... disease? Based on the outcomes of ... (ECP) has improved the quality of their ... normal activities of daily living. , ,MedCath ...
... Type 300 ,Oblique 45, ,Type ... coaxial illumination by setting the illumination ... should be ideal for use in ... no other conventional compact microscope can; ...
... holmium laser combines excellent cutting, ablation ... bloodless procedures. It is also extremely ... bladder stones of all compositions, making ... Because its laser light is transmitted ...
Medicine Products: